News and Media
Media Mentions
More mentionsNovel allergen inhibitor successfully prevents peanut reaction in mice
April 19, 2023
As Başar Bilgiçer co-author of the study explained, the reality is that “in the case of peanut allergy, there is no pathogen, just peanut proteins.”
Peanut allergy drug staves off anaphylaxis for 2 weeks with a single dose
February 13, 2023
“These new findings suggest that cHBI has the potential to be an effective preventative for peanut-specific allergic responses in patients,” said co-senior author Basar Bilgicer, Ph.D.
WSBT TV
Severe peanut allergy breakthrough by Indiana University and Notre Dame researchers
February 10, 2023
Professor Basar Bilgicer and his students have been hard at work on this project. It's one he's been invested in since 2008 and it's not a program that could've been rushed.
Originally published at news.nd.edu.
WSBT TV
Severe peanut allergy breakthrough by Indiana University and Notre Dame researchers
February 09, 2023
“Sometimes, we do have quantum leaps and make a huge discovery that may take us from one point to the next in a single experiment. this is not one of them, we had to take small steps every day to keep moving, just like the story of the tortoise and the hare,” said Basar Bilgicer, professor of chemical and biomolecular engineering at Notre Dame.
PBS
Peanut Allergies are on the Rise. This Chemical Compound Could Prevent Life-Threatening Reactions.
April 08, 2019
“Our method is a high precision tool that can block the responsible [immune molecules] and nothing else,” Bilgicer says. “Hopefully, that means it will start working from day one.”
